Changchun Genescience Pharmaceutical Co., Ltd.

This early-stage study is testing the safety of a new medication called GenSci098 for people with Graves' disease, an autoimmune condition that causes overactive thyroid. Researchers will give 24 participants increasing doses of the drug to check for side effects and see how the …

This study is testing whether a new, longer-acting growth hormone injection works better than the standard version for children who are short because they were born small for their gestational age. About 72 prepubertal children will receive either one of two doses of the new medi…

This is the first time a new drug called GenSci139 is being tested in people. The study aims to find a safe dose and see how the body processes the drug in patients with advanced solid tumors that have spread or cannot be removed by surgery. Researchers will also look for early s…

This early-stage study aims to test the safety and side effects of a new injectable drug called GenSci098 in people with thyroid eye disease. Researchers will give increasing doses to 76 participants to see how their bodies handle the medication and monitor for any problems. The …

This is the first study in people to test a new drug called GenSci143 for advanced solid tumors. The main goals are to find a safe dose and see how the body processes the drug. It is for adults whose cancer has continued to grow despite standard treatments or who have no other tr…

This is the first study in people to test a new drug called GenSci140 for advanced solid tumors, like ovarian cancer. The main goals are to find a safe dose, understand how the body processes the drug, and see if it shows any early signs of helping to control the cancer. The stud…

This study aims to find out which of two existing medications works better for women with high prolactin levels, a hormone condition that can affect menstrual cycles and fertility. Researchers will compare cabergoline tablets against bromocriptine tablets in 382 female participan…

This is the first study in people to test a new oral drug called GenSci128. It aims to see if the drug is safe and tolerable for patients with advanced solid tumors that have a specific genetic mutation called TP53 Y220C. The study will also look at how the drug moves through the…

This study is observing how well an existing medication works for cancer patients suffering from cachexia, a condition causing severe weight loss and loss of appetite. It will follow 495 adult patients who are already scheduled to take the drug in their normal care. The main goal…

This study is testing if a drug called nanocrystalline megestrol acetate can help people with advanced lung cancer keep their appetite and body weight up while they undergo combined chemotherapy and radiation. It compares the drug to a placebo (inactive pill) when both are given …

This is the first human study of an experimental drug called GenSci136, which is being developed for autoimmune diseases. Researchers are testing it in 48 healthy adults in China to check for side effects and see how the body processes it. The study will give different doses to s…

This is an early safety study to see how healthy adults tolerate a new drug called GS3-007a. Researchers will give different doses to small groups of volunteers to check for side effects and measure how the drug moves through the body. The goal is to gather basic safety informati…